MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines.
about
Role of an imbalanced miRNAs axis in pathogenesis of psoriasis: novel perspectives based on review of the literaturePrognostic role of microRNA-203 in various carcinomas: evidence from a meta-analysis involving 13 studiesDiscovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomyAn update on the LIM and SH3 domain protein 1 (LASP1): a versatile structural, signaling, and biomarker proteinLoss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migration.Prostate cancer invasion and metastasis: insights from mining genomic data.A MicroRNA/Ubiquitin Ligase Feedback Loop Regulates Slug-Mediated Invasion in Breast Cancer.Involvement of FAK-ERK2 signaling pathway in CKAP2-induced proliferation and motility in cervical carcinoma cell lines.MiR-203 Interplays with Polycomb Repressive Complexes to Regulate the Proliferation of Neural Stem/Progenitor CellsmiR-203 regulates progenitor cell proliferation during adult zebrafish retina regeneration.The transient expression of miR-203 and its inhibiting effects on skeletal muscle cell proliferation and differentiation.miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinaseInduction of cell proliferation and survival genes by estradiol-repressed microRNAs in breast cancer cells.A novel network integrating a miRNA-203/SNAI1 feedback loop which regulates epithelial to mesenchymal transition.MicroRNAs as predictive biomarkers and therapeutic targets in prostate cancer.miR-105/Runx2 axis mediates FGF2-induced ADAMTS expression in osteoarthritis cartilage.miR-203 regulates cell proliferation through its influence on Hakai expression.Inhibition of BCR/ABL protein expression by miR-203 sensitizes for imatinib mesylateRunx2-Smad signaling impacts the progression of tumor-induced bone diseasemiR-203 inhibits cell proliferation and migration of lung cancer cells by targeting PKCĪ±High-throughput sequencing of small RNA transcriptomes reveals critical biological features targeted by microRNAs in cell models used for squamous cell cancer research.BANF1 is downregulated by IRF1-regulated microRNA-203 in cervical cancer.Clinically relevant microRNAs in ovarian cancermiR-203 suppresses the proliferation and migration and promotes the apoptosis of lung cancer cells by targeting SRC.Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease.Hepatitis B virus replication and sex-determining region Y box 4 production are tightly controlled by a novel positive feedback mechanism.Epigenetic Silencing of miR-203 Upregulates SNAI2 and Contributes to the Invasiveness of Malignant Breast Cancer Cells.Association between underexpression of microrna-203 and clinicopathological significance in hepatocellular carcinoma tissuesmiR-203 Acts as a Tumor Suppressor Gene in Osteosarcoma by Regulating RAB22AEpstein-Barr virus downregulates microRNA 203 through the oncoprotein latent membrane protein 1: a contribution to increased tumor incidence in epithelial cells.Rewiring of an epithelial differentiation factor, miR-203, to inhibit human squamous cell carcinoma metastasis.MicroRNA-203 regulates caveolin-1 in breast tissue during caloric restrictionRegulation of Cell Proliferation and Migration by miR-203 via GAS41/miR-10b Axis in Human Glioblastoma Cells.Prognostic significance of microRNA-203 in cholangiocarcinoma.p63 threonine phosphorylation signals the interaction with the WW domain of the E3 ligase ItchmiR-203 regulates nociceptive sensitization after incision by controlling phospholipase A2 activating protein expression.Nanoparticle modulation of the tumor microenvironment enhances therapeutic efficacy of cisplatin.An anti-let-7 sponge decoys and decays endogenous let-7 functions.Expression of miR-203 is decreased and associated with the prognosis of melanoma patients.miR-203 Functions as a Tumor Suppressor by Inhibiting Epithelial to Mesenchymal Transition in Ovarian Cancer
P2860
Q28071830-58691BC1-3D3B-487E-8529-76BB2C3B1EB4Q28080063-44D4F1AD-9AAD-459B-83C2-EC83800CB075Q28534277-DD624CF5-CCEC-4EF5-A33B-1A147AC44ED6Q30009240-1AAEFCAB-7538-48C7-8E55-32DC57E42C25Q30009388-E3F94745-9DB2-49BB-B3FB-5C5E20250BC4Q30656758-0671C8CF-B21D-4136-BD43-BE0224E3DF0EQ33676240-65844E61-1B3C-4DEB-93CB-F7E29386F982Q33704675-90F7565F-1A0B-45C4-9844-592FD531B7D7Q33905417-E89F7919-A8C5-49B5-95C3-5CD0387E497EQ33923204-1C09C736-5DFC-4EDF-A061-0F1BF3C787A4Q34007761-FF076936-1334-4251-9366-8FE25F12BFEFQ34013539-CB971EFA-BC4D-4CBB-93C2-D10D4F01D36AQ34133268-93714D6A-D300-42BF-B480-D3FD9E81CDD1Q34239006-E5DAA318-BE21-41E5-ACC5-04543483CE0EQ34448246-4A4B54D3-CDB9-4B91-B3BF-7C8F5997EE7BQ34511015-122BCFBF-1515-40BF-9A03-936182E10271Q34534146-AC5FDAA3-3324-457D-A7EE-3B0A7A493E25Q34685280-50D5E97C-5C7B-4717-9185-6293258414F8Q34898865-3FCD624C-D740-488D-915F-D182A198AD4DQ34989595-06FCB834-8FEE-4BAB-9C0C-7F09BC4B8CE5Q35026315-3E83878F-9F3B-4D0D-92BB-C3DD2BDDAD54Q35057804-8AE9B6C2-E2B2-4628-9CD4-8FCC71233B22Q35204609-62ECC827-C24C-4B65-8942-FE9241B82667Q35228579-6ACF04D8-D90F-433D-8086-1B903142EFFFQ35251618-F8FF35C2-77CE-4DF8-A6CD-6C038303FC9CQ35599865-D248A332-E1EB-4A90-8C4E-3AB189436B37Q35755187-C21D542E-B12A-4A7E-A8FD-6E0769D68B6EQ35776681-ECE6FF7F-2A09-4983-AD5C-EB1C222C4595Q35780039-1507294B-F0EC-4F19-BB18-523809261FAFQ35826192-97ADACD2-27FC-478A-98E5-4852298ADDB5Q35952663-7F093DB6-4358-45F8-A2EF-A970E1E80EA1Q35954880-CC8BB986-A2DD-414B-AC7F-B4A4D90BD927Q36088612-0B2A6A8C-36B6-4B43-8A2A-920E11A07D1BQ36095393-AE81F934-EE68-45E5-80A8-546B64DF69A7Q36183728-08950DD0-A5C6-4E1D-A3D0-BBC8B9EE4EE9Q36197696-2D5791C7-2735-45EE-8AE9-E7CC5C2DB5DEQ36217643-EAC587FB-0A1C-4BE8-8E11-864649DAAF64Q36235552-F16484B6-B8E0-4D96-B435-84237D069A42Q36375397-BFAAC85C-90BF-4871-8E22-286807F2F235Q36497625-462668BB-FF18-4C1A-9C77-1BD370302B5F
P2860
MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines.
description
2011 nĆ® lÅ«n-bĆ»n
@nan
2011幓ć®č«ę
@ja
2011幓č«ę
@yue
2011幓č«ę
@zh-hant
2011幓č«ę
@zh-hk
2011幓č«ę
@zh-mo
2011幓č«ę
@zh-tw
2011幓č®ŗę
@wuu
2011幓č®ŗę
@zh
2011幓č®ŗę
@zh-cn
name
MiR-203 controls proliferation ...... of prostate cancer cell lines.
@en
MiR-203 controls proliferation ...... of prostate cancer cell lines.
@nl
type
label
MiR-203 controls proliferation ...... of prostate cancer cell lines.
@en
MiR-203 controls proliferation ...... of prostate cancer cell lines.
@nl
prefLabel
MiR-203 controls proliferation ...... of prostate cancer cell lines.
@en
MiR-203 controls proliferation ...... of prostate cancer cell lines.
@nl
P2093
P50
P356
P1433
P1476
MiR-203 controls proliferation ...... of prostate cancer cell lines
@en
P2093
Alessia Latina
Amanda Formosa
Anna Maria Lena
Eleonora Candi
Gerry Melino
Giuditta ViticchiĆØ
Lea H Gregersen
Richard A Knight
Roberto Miano
Sergio Bernardini
P304
P356
10.4161/CC.10.7.15180
P577
2011-04-01T00:00:00Z